Birc3 | List of Frontiers open access articles

Original Research

Published on 31 Dec 2013

Anti-Apoptotic Signature in Thymic Squamous Cell Carcinomas – Functional Relevance of Anti-Apoptotic BIRC3 Expression in the Thymic Carcinoma Cell Line 1889c

in Thoracic Oncology

Bei Huang
Djeda Belharazem
Li Li
Susanne Kneitz
Philipp Schnabel
Ralf Rieker
Daniel Körner
Winnfried Nix
Berthold Schalke
Hans Konrad Müller-Hermelink

Frontiers in Oncology

doi 10.3389/fonc.2013.00316

8,859 views
24 citations

Original Research

Published on 06 Oct 2021

Genetic Variants of CLEC4E and BIRC3 in Damage-Associated Molecular Patterns-Related Pathway Genes Predict Non-Small Cell Lung Cancer Survival

in Thoracic Oncology

Lihua Liu
Hongliang Liu
Sheng Luo
Edward F. Patz
Carolyn Glass
Li Su
Lijuan Lin
David C. Christiani
Qingyi Wei

Frontiers in Oncology

doi 10.3389/fonc.2021.717109

4,139 views
7 citations

Mini Review

Published on 05 Sep 2024

E3 ubiquitin ligase gene BIRC3 modulates TNF-induced cell death pathways and promotes aberrant proliferation in rheumatoid arthritis fibroblast-like synoviocytes

in Molecular Innate Immunity

Qingliang Meng
Kai Wei
Yu Shan

Frontiers in Immunology

doi 10.3389/fimmu.2024.1433898

7,696 views
29 citations

Original Research

Published on 23 Jun 2022

Integrated Analysis of Transcriptome mRNA and miRNA Profiles Reveals Self-Protective Mechanism of Bovine MECs Induced by LPS

in Veterinary Infectious Diseases

Ling Chen
Xiaolin Liu
Zhixiong Li
Jian Wang
Rongfu Tian
Huilin Zhang

Frontiers in Veterinary Science

doi 10.3389/fvets.2022.890043

5,030 views
16 citations

Original Research

Published on 09 Feb 2023

Overexpressed Nup88 stabilized through interaction with Nup62 promotes NF-κB dependent pathways in cancer

in Molecular and Cellular Oncology

Usha Singh
Divya Bindra
Atul Samaiya
Ram Kumar Mishra

Frontiers in Oncology

doi 10.3389/fonc.2023.1095046

6,316 views
15 citations

Original Research

Published on 02 Dec 2025

Epigenetic activation of CD274/PD-L1 by the MSL complex expands its role beyond dosage compensation

in Cancer Immunity and Immunotherapy

Aiping Wen
Xuanfei Feng
Yingying Li
Xueli Cui
Qixian Zou
Yong Cai
Jingji Jin
Yunxiao He

Frontiers in Immunology

doi 10.3389/fimmu.2025.1711451

1,596 views

Review

Published on 08 Nov 2022

Cardiovascular adverse events in chronic myeloid leukemia patients treated with nilotinib or imatinib: A systematic review, meta-analysis and integrative bioinformatics analysis

in Cardio-Oncology

Sicong Li
Jinshan He
Xinyi Zhang
Yuchun Cai
Jian Liu
Xiaoyan Nie
Luwen Shi

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.966182

12,190 views
26 citations

Articles

Anti-Apoptotic Signature in Thymic Squamous Cell Carcinomas – Functional Relevance of Anti-Apoptotic BIRC3 Expression in the Thymic Carcinoma Cell Line 1889c

Genetic Variants of CLEC4E and BIRC3 in Damage-Associated Molecular Patterns-Related Pathway Genes Predict Non-Small Cell Lung Cancer Survival

E3 ubiquitin ligase gene BIRC3 modulates TNF-induced cell death pathways and promotes aberrant proliferation in rheumatoid arthritis fibroblast-like synoviocytes

Integrated Analysis of Transcriptome mRNA and miRNA Profiles Reveals Self-Protective Mechanism of Bovine MECs Induced by LPS

Overexpressed Nup88 stabilized through interaction with Nup62 promotes NF-κB dependent pathways in cancer

Epigenetic activation of CD274/PD-L1 by the MSL complex expands its role beyond dosage compensation

Cardiovascular adverse events in chronic myeloid leukemia patients treated with nilotinib or imatinib: A systematic review, meta-analysis and integrative bioinformatics analysis